Indivior PLC (LON:INDV – Get Free Report) shares were up 11.1% on Friday . The stock traded as high as GBX 799 ($10.66) and last traded at GBX 772 ($10.30). Approximately 551,238 shares were traded during mid-day trading, a decline of 49% from the average daily volume of 1,087,031 shares. The stock had previously closed at GBX 695 ($9.27).
Indivior Trading Up 2.1 %
The company has a market capitalization of £1.23 billion, a P/E ratio of -653.37, a PEG ratio of -5.57 and a beta of 0.19. The company has a debt-to-equity ratio of -170.06, a current ratio of 0.83 and a quick ratio of 1.52. The business’s 50-day moving average price is GBX 723.43 and its two-hundred day moving average price is GBX 802.80.
Indivior Company Profile
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Recommended Stories
- Five stocks we like better than Indivior
- Breakout Stocks: What They Are and How to Identify Them
- 2 Strong Utilities Plays With Booming Earnings and Room to Grow
- 3 Tickers Leading a Meme Stock Revival
- Why Smart Investors Don’t Panic in Election Season
- How to Calculate Stock Profit
- Now Is the Time to Buy ServiceNow—The Rebound Is Real
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.
